Second cancers after adjuvant tamoxifen therapy for breast cancer.
Cook
L S
LS
Weiss
N S
NS
Potts
M S
MS
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000453:epidemiology* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D015994:Incidence; D016609:Neoplasms, Second Primary / Q000453:epidemiology* / Q000209:etiology*; D018426:SEER Program; D012680:Sensitivity and Specificity; D013629:Tamoxifen / Q000009:adverse effects*; D014481:United States / Q000453:epidemiology
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen